lerdelimumab

As nouns the difference between surgery and lerdelimumab

is that surgery is (medicine) a procedure involving major incisions to remove, repair, or replace a part of a body while lerdelimumab is a human monoclonal antibody and immunosuppressive drug developed to reduce scarring after glaucoma drainage surgery.

As nouns the difference between drainage and lerdelimumab

is that drainage is a natural or artificial removal of surface and sub-surface water from a given area while lerdelimumab is a human monoclonal antibody and immunosuppressive drug developed to reduce scarring after glaucoma drainage surgery.

As nouns the difference between glaucoma and lerdelimumab

is that glaucoma is an eye disease or disorder that is defined as a characteristic optic neuropathy, or disease of the optic nerve, possibly, if untreated, leading to damage of the optic disc of the eye and resultant visual field loss due to lack of communication between the retina and the brain, which can lead to blindness while lerdelimumab is a human monoclonal antibody and immunosuppressive drug developed to reduce scarring after glaucoma drainage surgery.

As nouns the difference between scarring and lerdelimumab

is that scarring is a scar; a mark while lerdelimumab is a human monoclonal antibody and immunosuppressive drug developed to reduce scarring after glaucoma drainage surgery.

As a verb scarring

is .

As nouns the difference between drug and lerdelimumab

is that drug is (pharmacology) a substance used to treat an illness, relieve a symptom, or modify a chemical process in the body for a specific purpose or drug can be (obsolete) a drudge while lerdelimumab is a human monoclonal antibody and immunosuppressive drug developed to reduce scarring after glaucoma drainage surgery.

As a verb drug

is to administer intoxicating drugs to, generally without the recipient's knowledge or consent or drug can be (drag).

As nouns the difference between immunosuppressive and lerdelimumab

is that immunosuppressive is (pharmacology) an agent which is capable of immunosuppression while lerdelimumab is a human monoclonal antibody and immunosuppressive drug developed to reduce scarring after glaucoma drainage surgery.

As an adjective immunosuppressive

is (pharmacology) having the capability to suppress the immune system, capable of immunosuppression.

As an adjective human

is (label) classical (of or pertaining to the classical - latin, greek - languages, literature, history and philosophy).

As a noun lerdelimumab is

a human monoclonal antibody and immunosuppressive drug developed to reduce scarring after glaucoma drainage surgery.